Trump’s proposed Medicare drug pricing experiment raises questions concerning the appropriateness of the method used to calculate the international price index, and the fact that U.S. prices would piggyback on price controls set in non-U.S. jurisdictions.
Trump’s Proposed Medicare Drug Pricing Experiment Stokes Fears Of Price Controls
